Abstract

BackgroundDespite proven efficacy of the prevention mother-to-child transmission of HIV strategy, its adoption in Africa has remained slow. In Kenya, its effectiveness remain unknown. The aim of this study was to assess the effectiveness of a prevention of mother-to-child transmission program in Kenya.MethodsThis retrospective cross-sectional study analyzed 2,642 records of HIV-exposed infants who had a deoxyribonucleic acid polymerase chain reaction test done. The main outcome measure was HIV vertical transmission rates, stratified by i) infant age at diagnosis, ii) maternal prophylaxis and iii) infant mode of feeding. The characteristics of the infants who tested positive were compared to those who tested negative using Chi-square and Wilcoxon-Ranksum test. Bivariate and multivariate logistic regression analyses were conducted to establish associations and explore relationship between covariates and HIV transmission.ResultsOne thousand and one hundred nineteen (42.4%) infants had dried blood spot samples taken for HIV deoxyribonucleic acid polymerase chain reaction test within the first 6 weeks of age. Median age at diagnosis for HIV-positive infants was 4 months (IQR 1.5–9) while that of HIV-negative infants was 2 months (IQR 1.5–6). In total, 1,906 (72.1%) infants received prophylactic antiretrovirals. Infants whose mothers received prophylaxis had significantly lower vertical transmission rate (6.7%) compared to those whose mothers did not receive prophylaxis (24.0%), (OR 0.23, p < 0.001). When adjusted for feeding option and infant’s age at diagnosis, the odds of transmission among women who received prophylaxis was 76% lower than that of women who did not receive any prophylaxis (OR 0.2 p < 0.001). 1,368 infants less than 6 months of age, 67.3%) were exclusively breastfed, 214 (10.5%) were replacement fed, and 164 (8.1%) mixed fed. Mixed feeding was associated with increased risk of HIV transmission (OR 2.7, p = 0.007). 67% of children older than 6 months were breastfed and had higher HIV transmission rate compared to those who were not breastfed (OR 2.3, p = 0.006).ConclusionsThe recorded rate of 9.3%, suggest the interventions implemented at the study sites were moderately effective, more so when provided early. Program performance will improve should the 12.8% of pregnant women who did not receive antiretroviral prophylaxis are reached.

Highlights

  • Despite proven efficacy of the prevention mother-to-child transmission of Human immunodeficiency virus (HIV) strategy, its adoption in Africa has remained slow

  • It has been established that women and infants who do not access prevention of mother-to-child transmission (PMTCT) intervention have 15– 30% risk of mother-tochild transmission (MTCT) in pregnancy and delivery, which increases to 20–45% during breastfeeding [7]

  • Description of infants in the study Infant age in the dataset ranged from birth to 18 months distributed as follows: 42% aged 6 weeks and below, 48% aged between 6 weeks and 9 months, 9% were above 9 months and only 1% were missing age variable

Read more

Summary

Introduction

Despite proven efficacy of the prevention mother-to-child transmission of HIV strategy, its adoption in Africa has remained slow. The World Health Organization (WHO) issued the consolidated guidelines in 2013, recommending lifelong use of antiretroviral therapy (ART) for all pregnant women regardless of their CD4 count [2, 3]. This intervention is referred to as prevention of mother-to-child transmission (PMTCT) option B+. Infant Diagnosis (EID) remains a key test in measuring the extent to which PMTCT interventions have averted MTCT It is the entry point for HIV-exposed infants (HEI) to early clinical evaluation, prophylaxis for opportunistic infections and ART [3]. Without any therapeutic intervention, up to 35 and 52% of HIV infected infants die by age one year and two years respectively [7, 8]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call